BLOOD-BRAIN BARRIER DYSFUNCTION ASSESSED BY PROTEIN S-100 BETA LEVELS IN CIRRHOTIC PATIENTS IN ICU by N Weiss et al.
POSTER PRESENTATION Open Access
Blood-brain barrier dysfunction assessed by protein
S-100 beta levels in cirrhotic patients in ICU
N Weiss1*, D Monneret2, F Imbert-Bismuth2, S Tripon3, M Mallet4, M Rudler4, D Thabut4,
Brain Liver Pitie-Salpetriere Study Group (BLIPS)
From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
The protein S-100 beta (PS-100) is a small dimeric cyto-
solic protein synthetized in astrocytes and Schwann cells.
High serum levels of PS-100 are associated with brain
lesions and altered blood-brain barrier permeability in
traumatic brain injury, ischemic stroke, cerebral tumors
and subarachnoid hemorrhage. Early brain damage has
been detected in patients with cirrhosis. We hypothesized
that those insults could be detected by the PS-100 serum
levels (normal values < 0.10 µg/L).
Objectives
Hence, the aim of the present study was to assess PS-100
levels in cirrhotic patients, and compare them to PS-100
levels in non-cirrhotic patients followed up in the same
department for initial workup of elevated liver enzymes
(controls).
Methods
We prospectively included a population of cirrhotic
patients admitted for complication of cirrhosis in ICU
and controls. Baseline data were recorded and levels of
ammonemia and PS-100 determined at admission. Overt
HE was diagnosed as a West-Haven score ranging
between 2 and 4.
Results
Between October 2013 and October 2014, 124 cirrhotic
patients (mean age: 63 years, male gender: 73%, etiology of
cirrhosis: alcoholic 51%, viral 25%, other 24%, Child-Pugh
11 [8-12], MELD score 21 [14-26]) and 79 non-cirrhotic
patients (mean age: 63 years, male 59%, etiology of ele-
vated liver enzymes: alcoholic 5%, viral 44%, NASH 38%,
other 13%, mean Fibroscan: 5.3 kPa, mean FibroTest:0.15)
were included. Among cirrhotic patients, 40 patients
(33%) displayed HE at admission and 50 (41%) had an
infection. Mean PS-100 level were 0,15 ± 0,01 for cirrhotic
patients and 0,07 ± 0,01 for non-cirrhotic patients (p <
0.0001). In cirrhotic patients, PS-100 was correlated to
AST (p = 0.0027), bilirubin (p = 0.0001), Child-Pugh score
(p = 0.001) and MELD (p = 0.0004) and inversely corre-
lated to albumin (p = 0.04), sodium (p = 0.01), PTT (p =
0.001), and FV (p = 0.011). PS-100 levels were not corre-
lated to the presence of overt HE nor to infection. In mul-
tivariate analysis, levels of PS-100 were independently
associated with MELD score (p = 0.0006), whereas overt
HE was associated to hyperammonemia (p = 0.002) and
the presence of infection (p = 0.008) but not to PS-100
levels.
Conclusions
Patients with cirrhosis in ICU display neurological insult
or blood-brain barrier dysfunction even in the absence
of overt HE. Brain damage is more frequent in patients
with advanced liver disease.
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